SCHEMBL24878752

SCHEMBL24878752

CCOC(=O)c1nn(CC(=O)O)c2c1[C@@H]1[C@H](C)[C@@H]1C2(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 3/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
MAPT P10636 6/20 0.33
TP53 P04637 1/20 0.32
ALOX12 P18054 1/20 0.32
GAA P10253 2/20 0.32
POLB P06746 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
HTT P42858 1/20 0.32
ELANE P08246 1/20 0.31
APP P05067 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16006682 0.80 PDE4A (0.33) ALDH1A1KDM4EHPGDHSD17B10PDE4A
SCHEMBL17695171 0.80 PDE4A (0.33) ALDH1A1KDM4EHPGDHSD17B10PDE4A
SCHEMBL21995999 0.80 PDE4A (0.33) ALDH1A1KDM4EHPGDHSD17B10PDE4A
SCHEMBL19788967 0.78 ADORA3 (0.33) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL21420064 0.76 LMNA (0.40) ALDH1A1KDM4EGAAHTTLMNA
SCHEMBL24088686 0.76 GAA (0.32) ALDH1A1GAALMNA
SCHEMBL24169552 0.76 GAA (0.32) ALDH1A1GAALMNA
SCHEMBL21695109 0.76 LMNA (0.40) ALDH1A1KDM4EGAAHTTLMNA
SCHEMBL22681237 0.76 GAA (0.32) ALDH1A1GAALMNA
SCHEMBL23793983 0.76 GAA (0.32) ALDH1A1GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230008022-A1 NOVEL SUBSTITUTED PIPERAZINE AMIDE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS MERCK SHARP & DOHME CORP. (US) 2023-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230008022-A1 NOVEL SUBSTITUTED PIPERAZINE AMIDE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS IDO1, IDO2, KYNU ALDH1A1 328/4885KDM4E 759/4885HPGD 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.